4-Hydroxybenzyl alcohol: A novel inhibitor of tumor angiogenesis and growth

Life Sciences

Volumn 93, Issue 1, 2013, Pages 44-50

  Laschke, Matthias W ^a   Vorsterman Van Oijen, Antonia E ^a   Körbel, Christina ^a   Scheuer, Claudia ^a   Menger, Michael D ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

4 Hydroxybenzyl alcohol; Angiogenesis; Colorectal cancer; Dorsal skinfold chamber; Intravital fluorescence microscopy; Tumor; Vascularization

Indexed keywords

4 HYDROXYBENZYL ALCOHOL; ANGIOGENESIS INHIBITOR; GELATINASE B; LACTATE DEHYDROGENASE; TETRAZOLIUM; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; CYTOSKELETON; DOSE RESPONSE; DRUG CYTOTOXICITY; ENZYME ASSAY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLEIOTROPY; PROTEIN EXPRESSION; SPHEROID CELL; TUMOR GROWTH; TUMOR VASCULARIZATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BENZYL ALCOHOLS; BLOTTING, WESTERN; CASPASE 3; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTOLOGICAL TECHNIQUES; IMMUNOHISTOCHEMISTRY; L-LACTATE DEHYDROGENASE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PHALLOIDINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; MUS;

EID: 84879501602     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.05.022     Document Type: Article

References (34)

1. A. Belicha-Villanueva, J. Riddell, N. Bangia, and S.O. Gollnick The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules Lasers Surg Med 44 2012 60 68
2. G. Bergers, and D. Hanahan Modes of resistance to anti-angiogenic therapy Nat Rev Cancer 8 2008 592 603
3. J.J. Bravo-Cordero, L. Hodgson, and J. Condeelis Directed cell invasion and migration during metastasis Curr Opin Cell Biol 24 2012 277 283
4. N. Cheung, P. Mitchell, and T.Y. Wong Diabetic retinopathy Lancet 376 2010 124 136
5. E. Descamps, M. Petrault-Laprais, P. Maurois, N. Pages, P. Bac, and R. Bordet Experimental stroke protection induced by 4-hydroxybenzyl alcohol is cancelled by bacitracin Neurosci Res 64 2009 137 142
6. H.F. Dvorak Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy J Clin Oncol 20 2002 4368 4380
7. N.T. Elliott, and F. Yuan A review of three-dimensional in vitro tissue models for drug discovery and transport studies J Pharm Sci 100 2011 59 74
8. J. Folkman Tumor angiogenesis: therapeutic implications N Engl J Med 285 1971 1182 1186
9. J. Folkman Fighting cancer by attacking its blood supply Sci Am 275 1996 150 154
10. M. Grimm, M. Gasser, M. Bueter, J. Strehl, J. Wang, and E. Nichiporuk Evaluation of immunological escape mechanisms in a mouse model of colorectal liver metastases BMC Cancer 10 2010 82
11. R. Heidenreich, M. Röcken, and K. Ghoreschi Angiogenesis drives psoriasis pathogenesis Int J Exp Pathol 90 2009 232 248
12. J.W. Jung, B.H. Yoon, H.R. Oh, J.H. Ahn, S.Y. Kim, and S.Y. Park Anxiolytic-like effects of Gastrodia elata and its phenolic constituents in mice Biol Pharm Bull 29 2006 261 265
13. O. Kollmar, K. Rupertus, C. Scheuer, B. Junker, B. Tilton, and M.K. Schilling Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis Neoplasia 9 2007 862 870
14. O. Kollmar, B. Junker, K. Rupertus, M.D. Menger, and M.K. Schilling Studies on MIP-2 and CXCR2 expression in a mouse model of extrahepatic colorectal metastasis Eur J Surg Oncol 33 2007 803 811
15. O. Kollmar, K. Rupertus, C. Scheuer, R.M. Nickels, G.C. Haberl, and B. Tilton CXCR4 and CXCR7 regulate angiogenesis and CT26.WT tumor growth independent from SDF-1 Int J Cancer 126 2010 1302 1315
16. T. Kubota, H. Fujiwara, H. Amaike, K. Takashima, S. Inada, and K. Atsuji Reduced HGF expression in subcutaneous CT26 tumor genetically modified to secrete NK4 and its possible relation with antitumor effects Cancer Sci 95 2004 321 327
17. M.W. Laschke, and M.D. Menger In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis Hum Reprod Update 13 2007 331 342
18. M.W. Laschke, Vorsterman van Oijen AE, C. Scheuer, and M.D. Menger In vitro and in vivo evaluation of the anti-angiogenic actions of 4-hydroxybenzyl alcohol Br J Pharmacol 163 2011 835 844
19. M.W. Laschke, B. Vollmar, and M.D. Menger The dorsal skinfold chamber: window into the dynamic interaction of biomaterials with their surrounding host tissue Eur Cell Mater 22 2011 147 164
20. M.W. Laschke, C. Giebels, R.M. Nickels, C. Scheuer, and M.D. Menger Endothelial progenitor cells contribute to the vascularization of endometriotic lesions Am J Pathol 178 2011 442 450
21. J.Y. Lee, Y.W. Jang, H.S. Kang, H. Moon, S.S. Sim, and C.J. Kim Anti-inflammatory action of phenolic compounds from Gastrodia elata root Arch Pharm Res 29 2006 849 858
22. Y.J. Lee, D.L. Karl, U.N. Maduekwe, C. Rothrock, S. Ryeom, and P.A. D'Amore Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environment Cancer Res 70 2010 8357 8367
23. M. Leunig, F. Yuan, M.D. Menger, Y. Boucher, A.E. Goetz, and K. Messmer Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice Cancer Res 52 1992 6553 6560
24. E.J. Lim, H.J. Kang, H.J. Jung, and E.H. Park Anti-angiogenic, anti-inflammatory and anti-nociceptive activity of 4-hydroxybenzyl alcohol J Pharm Pharmacol 59 2007 1235 1240
25. L.M. Ojemann, W.L. Nelson, D.S. Shin, A.O. Rowe, and R.A. Buchanan Tian ma, an ancient Chinese herb, offers new options for the treatment of epilepsy and other conditions Epilepsy Behav 8 2006 376 383
26. L. Ouyang, Z. Shi, S. Zhao, F.T. Wang, T.T. Zhou, and B. Liu Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis Cell Prolif 45 2012 487 498
27. F. Shojaei Anti-angiogenesis therapy in cancer: current challenges and future perspectives Cancer Lett 320 2012 130 137
28. P. Vajkoczy, A. Ullrich, and M.D. Menger Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation Neoplasia 2 2000 53 61
29. M.J. Waldner, and M.F. Neurath Targeting the VEGF signaling pathway in cancer therapy Expert Opin Ther Targets 16 2012 5 13
30. L. Wang, B. Yao, Q. Li, K. Mei, J.R. Xu, and H.X. Li Gene therapy with recombinant adenovirus encoding endostatin encapsulated in cationic liposome in coxsackievirus and adenovirus receptor-deficient colon carcinoma murine models Hum Gene Ther 22 2011 1061 1069
31. J.M. Wu, and C.A. Staton Anti-angiogenic drug discovery: lessons from the past and thoughts for the future Expert Opin Drug Discov 7 2012 723 743
32. S.J. Yu, J.R. Kim, C.K. Lee, J.E. Han, J.H. Lee, and H.S. Kim Gastrodia elata blume and an active component, p-hydroxybenzyl alcohol reduce focal ischemic brain injury through antioxidant related gene expressions Biol Pharm Bull 28 2005 1016 1020
33. S.S. Yu, J. Zhao, W.P. Zheng, and Y. Zhao Neuroprotective effect of 4-hydroxybenzyl alcohol against transient focal cerebral ischemia via anti-apoptosis in rats Brain Res 1308 2010 167 175
34. S.S. Yu, J. Zhao, S.P. Lei, X.M. Lin, L.L. Wang, and Y. Zhao 4-Hydroxybenzyl alcohol ameliorates cerebral injury in rats by antioxidant action Neurochem Res 36 2011 339 346